Complications of therapy with lysergide.
All known complications which occurred during and after LSD treatment of 237 psychiatric patients on an open ward of a general hospital are described and classified. The results imply that clinical research with lysergide can be carried out in similar settings with relative safety.
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced; D000368:Aged; D000437:Alcoholism / Q000188:drug therapy; D003072:Cognition Disorders / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D005260:Female; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009497:Neurotic Disorders / Q000188:drug therapy; D010468:Perceptual Disorders / Q000139:chemically induced; D010554:Personality Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy
D008238:Lysergic Acid Diethylamide